Efficacy and safety studies on fovea-sparing internal limiting membrane peeling for myopic foveoschisis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000036087

Enrollment

Unknown

Registered

2020-08-21

Start date

2020-09-01

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopic foveoschisis

Interventions

Case series:fovea-sparing internal limiting membrane peeling

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with myopic foveoschisis receiving surgical treatment

Exclusion criteria

Exclusion criteria: 1. Accompany with other diseases which decrease visual acuity, such macular hole, retinal detachment or glaucoma; 2. patients with silicon oil tamponade during surgery.

Design outcomes

Primary

Measure	Time frame
best corrected visual acuity;incidence of Iatrogenic macular hole formation;	—

Countries

China

Contacts

Public ContactZheng Dezhi

Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong

15989849662@163.com+86 15989849662

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026